Psychiatric Times • Aug 7 2023
According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.
Class is now in session, but young patients with attention-deficit/hyperactivity disorder (ADHD) might not be ready to face the classroom. Thousands—if not millions—of them may not have their medication.
The US Food and Drug Administration (FDA) originally announced a shortage of immediate- release formulation of amphetamine mixed salts (Adderall) on October 12, 2022.1 According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023.2 Other generic amphetamine mixed salts are predicted to be in shortage until the end of August 2023, September 2023, and December 2023 (Table).3 Additionally, some methylphenidate extended-release tablets were discontinued in January 2023, whereas others are in shortage due to an active ingredient issue.4 This may cause increased concern among young patients with ADHD and their families as the school year starts up, especially amid what is being called the “crisis of our time” in terms of children’s mental health.5